Pinealon: Brain & Pineal Gland Bioregulator Research
Tripeptide bioregulator for neuroprotection and circadian function
Source: https://indexalabs.com/blog/pinealon-bioregulator-brain-pineal-research Abstract: Pinealon (Glu-Asp-Arg) is a synthetic tripeptide bioregulator targeting the pineal gland and central nervous system. Research focuses on its potential neuroprotective effects, circadian rhythm regulation, and cognitive support in aging models.
1. Overview & Background
1.1 What is Pinealon? Pinealon is a synthetic tripeptide (Glu-Asp-Arg) designed to support pineal gland and brain tissue function. It belongs to the cytogen class of Khavinson bioregulators.
1.2 Target Tissues Primary: Pineal gland and pinealocytes Secondary: Neurons, glial cells, and broader CNS tissue
1.3 Research Focus Studies examine Pinealon’s effects on melatonin synthesis, neuroprotection, and cognitive function in aging and stress models.
2. Mechanisms of Action
2.1 Gene Expression Modulation Research indicates Pinealon may upregulate genes involved in melatonin synthesis and antioxidant defense in pineal tissue.
2.2 Pinealocyte Support Studies suggest support for pinealocyte viability and function, potentially counteracting age-related pineal calcification effects.
2.3 Neuroprotection In vitro studies show potential protective effects against oxidative stress and excitotoxicity in neuronal cultures.
2.4 Circadian Regulation May support healthy circadian rhythm through effects on the pineal-hypothalamic axis.
3. Research Evidence
3.1 Animal Studies Studies in aging rodents show improvements in learning, memory, and sleep architecture with Pinealon administration.
3.2 Cell Culture Studies Demonstrated protective effects on cortical neurons exposed to beta-amyloid and oxidative stress.
3.3 Melatonin Studies Research indicates potential restoration of melatonin production in aged animals.
3.4 Cognitive Assessments Behavioral studies show improvements in maze navigation and memory retention tasks.
4. Research Protocols
4.1 Vial Size Available in 20mg vials for research applications.
4.2 Timing Considerations Evening administration aligns with natural pineal gland activity patterns.
4.3 Cycle Protocols Traditional research uses 10-20 day cycles followed by extended rest periods.
4.4 Combinations Often studied alongside other neuroprotective agents and complementary bioregulators like Vilon.